What is the recommended approach for tapering off lorazepam (Ativan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Tapering Protocol

For lorazepam tapering, reduce the dose by 10% of the most recent dose every 2-4 weeks, with slower reductions (10% per month or less) for patients on long-term therapy (≥1 year). 1

Critical Safety Principles

  • Never abruptly discontinue lorazepam except in cases of confirmed diversion or serious medical toxicity, as abrupt cessation can precipitate life-threatening withdrawal reactions including seizures and death. 1, 2
  • Benzodiazepine withdrawal carries greater risks than opioid withdrawal and must always be conducted gradually. 3
  • If the patient is taking both opioids and benzodiazepines, taper the benzodiazepine first due to higher withdrawal risks. 3

Standard Tapering Schedule

For Standard Cases (Short-to-Intermediate Term Use)

  • Reduce by 10% of the most recent dose every 2-4 weeks. 1
  • For example, if taking 2 mg daily, reduce by 0.2 mg every 2-4 weeks. 1

For Long-Term Users (≥1 Year)

  • Use slower reductions of 10% per month or less. 1
  • Patients with prolonged use require tapers extending over months. 4, 3
  • The guideline recommends reductions of 25% of the initial dose every 1-2 weeks as an alternative approach, though this may be too rapid for some patients. 3

Managing the Taper Process

Before Starting

  • Obtain patient agreement and involvement in the tapering plan to improve success rates. 1
  • Set realistic expectations about the tapering process and potential withdrawal symptoms. 1
  • Evaluate duration of use, as longer-term users require slower tapers. 1

During the Taper

  • Monitor for withdrawal symptoms after each dose reduction before proceeding to the next step. 1
  • Watch specifically for increased anxiety, depression, seizures, and altered mental status. 4, 3
  • If withdrawal symptoms become severe, return to the previous well-tolerated dose and slow the taper further. 1
  • Monitor patients at least monthly during the tapering process. 1

Common Withdrawal Symptoms to Anticipate

  • Increased anxiety, insomnia, tremor, sweating, tachycardia, headache, muscle aches, and weakness. 5
  • More severe symptoms can include confusion, heightened sensory perception, paresthesias, and seizures. 6

Adjunctive Strategies

Pharmacological Support

  • Gabapentin can help mitigate withdrawal symptoms during tapering. Start with 100-300 mg at bedtime or three times daily, increasing by 100-300 mg every 1-7 days as tolerated. 3
  • Carbamazepine may help with withdrawal symptoms, though it can affect metabolism of some benzodiazepines. 3
  • Pregabalin has shown potential benefit in facilitating tapering. 3
  • SSRIs (particularly paroxetine) may manage underlying anxiety during tapering. 3
  • Clonidine (an α2-adrenergic agonist) can be considered for autonomic withdrawal symptoms. 1

Non-Pharmacological Approaches

  • Cognitive behavioral therapy (CBT) during the taper increases success rates and should be incorporated. 3, 1
  • Include mindfulness, relaxation techniques, and psychotherapy. 3
  • Encourage regular exercise. 1
  • Provide patient education about benzodiazepine risks and benefits of tapering to improve outcomes. 3

When to Refer to a Specialist

Refer rather than attempt primary care tapering if the patient has: 4, 3

  • History of withdrawal seizures
  • Other significant medical comorbidities
  • Co-occurring substance use disorders
  • Unreliable history about amount being taken
  • Poor motivation or adherence
  • Failed office-based tapering attempts

Critical Pitfalls to Avoid

  • Do not taper too quickly (faster than 10% reduction every 2-4 weeks). 1
  • Do not set arbitrary time limits for completing the taper. 1
  • Do not abandon patients who are struggling with the taper; consider pausing the reduction rather than discontinuing care. 1
  • Do not prescribe opioids and benzodiazepines simultaneously whenever possible due to increased risk of respiratory depression and death. 3, 2

Special Populations

Elderly Patients

  • Consider a more gradual taper with smaller dose reductions to minimize adverse effects. 3

Patients with Co-occurring Opioid Use

  • If both medications need discontinuation, reduce benzodiazepines first due to higher withdrawal risks. 3
  • If opioids must be continued, prescribe the lowest effective dosages and monitor closely for respiratory depression. 2

References

Guideline

Lorazepam Tapering Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Discontinuation reactions to alprazolam in panic disorder.

Journal of psychiatric research, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.